PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.
about
NOD1 deficiency impairs CD44a/Lck as well as PI3K/Akt pathway.Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.Cariporide Enhances the DNA Damage and Apoptosis in Acid-tolerable Malignant Mesothelioma H-2452 CellsDeoxyelephantopin and Isodeoxyelephantopin as Potential Anticancer Agents with Effects on Multiple Signaling Pathways.Quantitative proteomics profiling reveals activation of mTOR pathway in trastuzumab resistance.Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies.Functional evaluation of synthetic flavonoids and chalcones for potential antiviral and anticancer properties.New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.MicroRNA-184 Modulates Human Central Nervous System Lymphoma Cells Growth and Invasion by Targeting iASPP.Analysis of differential gene expression profile identifies novel biomarkers for breast cancer.Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models.Association between single nucleotide polymorphisms in the PI3K/AKT/mTOR pathway and bladder cancer risk in a sample of Iranian population.Treating breast cancer metastasis with cabazitaxel-loaded polymeric micelles.tsRNA signatures in cancer.Skp2-dependent reactivation of AKT drives resistance to PI3K inhibitors.Vav1 down-modulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome.Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway.Global Expression Profiling and Pathway Analysis of Mouse Mammary Tumor Reveals Strain and Stage Specific Dysregulated Pathways in Breast Cancer Progression.MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.Anti‑cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K/Akt/mTOR pathway: In vitro and in vivo studies.Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells.A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancerChemical modulation of autophagy as an adjunct to chemotherapy in childhood and adolescent brain tumors
P2860
Q33774237-75331DA2-3BC3-4367-904A-EA3D87633D6EQ33888946-26E60B1C-EB7A-48EE-A47B-8C695CABAA5DQ38611440-EEF7EB82-2337-4A12-A41B-B66B0D93516EQ38699551-FB013BCA-ABBF-4F01-A275-86E8EC606683Q38703402-0F0F073B-965E-4DDF-A96F-320E2E02FF99Q39375196-1788F205-16BE-411A-998E-549BA2BFEDFFQ40228338-3D597777-7E73-4A59-8150-8DF7BE76507DQ47246957-8CE44AD5-3796-4AA6-9DE1-942C27A016F5Q48383783-38B29A96-ECAA-4050-B186-CCE0A3BA930BQ49188421-3041BBC8-3480-4FDE-9E50-B259CC64660AQ49197891-C54ACC13-4DD4-410A-9791-9F9E0D5B91E6Q49570244-61363473-52D2-4128-B56D-F4E9A4DB1A49Q50642716-731B6323-43C6-4881-9E0F-3669DFBEA1EEQ50897488-01009B3E-5A9B-40EC-9A74-EA0D39EC182FQ52356988-7D08C992-DCAE-4B6E-9B42-78BED45A36B6Q52586939-B27DB910-5AD0-487B-9F65-37EBE083F99FQ52664077-DD352478-3AEF-489C-B668-3EE804D4B547Q52715481-CDA17476-8185-4CB7-87B2-64417BDB33AEQ52747351-BBC39578-F1BD-4265-8265-11BC3D6C021BQ54979331-7C48573E-5837-4A51-8826-FF2BF70A3E3CQ55027564-0128CE32-885C-4DD6-8166-BDC6269E8FF3Q55240690-2C07665F-F942-4379-B54D-05765BB1942CQ58743761-F7807E44-5332-4D69-B0C1-B0EB18567932Q59133202-FA446860-04AE-45C2-90DF-FA12423FAFDE
P2860
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.
@en
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.
@nl
type
label
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.
@en
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.
@nl
prefLabel
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.
@en
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.
@nl
P2093
P2860
P1476
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.
@en
P2093
Angel Guerrero-Zotano
Carlos L Arteaga
Ingrid A Mayer
P2860
P2888
P304
P356
10.1007/S10555-016-9637-X
P577
2016-11-28T00:00:00Z